Directory

>

Carl Uli Bialucha

avatar

Carl Uli Bialucha

Chief Scientific Officer | Xilio Therapeutics, Inc.

Cambridge, Massachusetts, United States

View contact details (it's free)

Carl Uli Bialucha

Summary

Carl Uli Bialucha is a seasoned Chief Scientific Officer at Xilio Therapeutics, Inc., specializing in cancer and immuno-oncology drug discovery. With a Ph.D. in Molecular Cell Biology from University College London, he has a robust background in biochemistry, biopharmaceuticals, and translational research. His leadership has been pivotal in guiding research teams to develop multiple clinical-stage molecules, showcasing his expertise in creating high-performing, multidisciplinary teams. Carl's career trajectory includes significant roles at renowned organizations such as Novartis and Immunitas Therapeutics, where he spearheaded innovative drug discovery initiatives. His commitment to advancing cancer therapeutics is evident through numerous publications in prestigious journals, reflecting his contributions to the field. Beyond his technical prowess, he has experience in company growth from Series A to IPO, emphasizing his business acumen in the biotech industry. Carl's passion for life sciences drives his continuous pursuit of impactful research and development in oncology.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Non-Profit Experience

Carl Uli Bialucha

Work Experience

company logo

Chief Scientific Officer at

Xilio Therapeutics, Inc.

August 2022 - Present

company logo

Scientific Advisory Board Member at

Terri Brodeur Breast Cancer Foundation (TBBCF)

August 2022 - Present

company logo

SVP of Research at

Xilio Therapeutics, Inc.

April 2021 - August 2022

company logo

VP, Drug Discovery at

Immunitas Therapeutics

December 2019 - April 2021

company logo

Director, Oncology Biotherapeutics at

Novartis

November 2016 - December 2019

company logo

Lab Head, Oncology Biotherapeutics at

Novartis

November 2010 - November 2016

💼

Postdoctoral Fellow, Cancer Genetics at

Cold Spring Harbor Laboratory Association, Inc.

April 2007 - November 2010

Logos provided by Logo.dev

Carl Uli Bialucha

Education

MRC Laboratory for Molecular Cell Biology (LMCB), University College London, Ph.D.

January 2002 - January 2007

University of California, San Francisco, Research Exchange Fellow

January 2003 - January 2003

University of Sussex, Bsc Hons

January 1999 - January 2002

Frequently Asked Questions about Carl Uli Bialucha

What is Carl Uli Bialucha email address?

Carl Uli Bialucha's primary email address is *********@xiliotx.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Carl Uli Bialucha work for?

Carl Uli Bialucha is a Chief Scientific Officer at Xilio Therapeutics, Inc., a company specializing in Commercial physical research.

Where Carl Uli Bialucha graduated from?

Carl Uli Bialucha holds a degree in Molecular Cell Biology from MRC Laboratory for Molecular Cell Biology (LMCB), University College London.

How can I directly contact Carl Uli Bialucha?

To contact Carl Uli Bialucha directly, you can use the email address *********@xiliotx.com. Complete contact information is available upon registration with Muraena.

Who is Carl Uli Bialucha?

Carl Uli Bialucha is a seasoned Chief Scientific Officer at Xilio Therapeutics, Inc., specializing in cancer and immuno-oncology drug discovery. With a Ph.D. in Molecular Cell Biology from University College London, he has a robust background in biochemistry, biopharmaceuticals, and translational research. His leadership has been pivotal in guiding research teams to develop multiple clinical-stage molecules, showcasing his expertise in creating high-performing, multidisciplinary teams. Carl's career trajectory includes significant roles at renowned organizations such as Novartis and Immunitas Therapeutics, where he spearheaded innovative drug discovery initiatives. His commitment to advancing cancer therapeutics is evident through numerous publications in prestigious journals, reflecting his contributions to the field. Beyond his technical prowess, he has experience in company growth from Series A to IPO, emphasizing his business acumen in the biotech industry. Carl's passion for life sciences drives his continuous pursuit of impactful research and development in oncology.

Carl`s contact details

mail

*********@xiliotx.com

Colleagues

avatar
Sean Ring

Senior Vice President, Corporate Development and Program Leadership

avatar
Teleen Norman

Senior Vice President Clinical Operations

avatar
Fraser Leslie

Senior Vice President Tech Ops

avatar
Rene Russo

Director

avatar
Scott Coleman

Chief Development Officer (CDO)

avatar
Scott Mcconnell

Vice President Clinical Science and Pharmacovigilance

avatar
Katarina Luptakova

Chief Medical Officer

avatar
Christopher Frankenfield

Chief Financial Officer and Chief Operating Officer

avatar
Margaret Karow

Founder and Chief Development Office

View Contact details (it's free)
Request Profile Removal